Microscopic polyangitis;La polyangeite microscopique

Annales de Medecine Interne

Volumn 151, Issue 3, 2000, Pages 193-198

  Venetz, Jean Pierre ^a   Rossert, Jérôme ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Microscopic polyangiitis

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; MEPREDNISONE;

CHRONIC KIDNEY FAILURE; CHURG STRAUSS SYNDROME; GLOMERULONEPHRITIS; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; REVIEW; VASCULITIS;

HUMANS; VASCULITIS;

EID: 0033933616     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. ANDRASSY K, KÜSTER S, WALDHERR R, RITZ E: Rapidly progressive glomerulonephritis: Analysis of prevalence and clinical course. Nephron, 1991: 59: 206-12.
2. PETTERSSON EE, SUNDELIN B, HEIGL Z: Incidence and outcome of pauci-immune necrotizing and crescentic glomerulonephritis in adults. Clin Nephrol, 1995; 43: 141-9.
3. SIMON P, RAMÉE MP, ANG KS, CAM G : Épidémiologie des maladies glomérulaires dans une région française. Variations en fonction des époques et de l'âge des sujets. Presse Med, 1988 ; 17 : 2175-8.
4. HOGAN SL, NACHMAN PH, WILKMAN AS, JENNETTE JC, FALK RJ, and the GLOMERULAR DISEASE COLLABORATIVE NETWORK: Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol, 1996; 7: 23-32.
5. SERRA A, CAMERON JS, TURNER DR, HARTLEY B, OGG CS, NEILD GH, et al.: Vasculitis affecting the kidney: presentation, histopathology and long-term outcome. Q J Med, 1984; 210: 181-207.
6. GODMAN GC, CHURG J. Wegener's granulomatosis: Pathology and review of the literature. Arch Pathol, 1954; 58: 533-53.
7. HUNDER GG, AREND WP, BLOCH DA, CALABRESE LH, FAUCI AS, FRIES JF, et al.: The American College of Rheumatology 1990 criteria for the classification of vasculitis: Introduction. Arthritis Rheum, 1990; 33: 1065-7.
8. JENNETTE JC, FALK RJ, ANDRASSY K, BACON PA, CHURG J, et al.: Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum, 1994; 37: 187-92.
9. BINDI P, MOUGENOT B, MENTRE F, NOEL LH, PERALDI MN, VANHILLE P, et al.: Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study. Q J Med. 1993; 86: 55-68.
10. SAVAGE COS, WINEARLS CG, EVANS DJ, REES AJ, LOCKWOOD CM: Microscopic polyarteritis: Presentation, pathology and prognosis. Q J Med, 1985; 220: 467-83.
11. D'AGATI V, CHANDER P, NASH M, MANCILLA-JIMENEZ R: Idiopathic microscopic polyarteritis nodosa: ultrastructural observations on the renal vascular and glomerular lesions. Am J Kidney Dis, 1986; 42: 95-110.
12. ADU D, HOWIE AJ, SCOTT DG, BACON PA, MCGONIGLE RJ, MICHEAL J: Polyarteritis and the kidney. Q J Med, 1987; 62: 221-37.
13. WESTMAN KWA, BYGREN PG, OLSSON H, RANSTAM J, WIESLANDER J: Relapse rate, renal suvival, and cancer morbidity in patients with wegener's granulomatosis or microscopic polynangiitis with renal involvement. J Am Soc Nephrol. 1998; 9: 842-52.
14. GUILLEVIN L, DURAND-GASSELIN B, CEVALLOS R, GAYRALD M, LHOTE F, CALLARD P, et al.: Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum, 1999; 42: 421-30.
15. HEILMAN RL, OFFORD KP, HOLLEY KE, VELOSA JA: Analysis of risk factors for patient and renal survival in crescentic glomerulonephritis. Am J Kidney Dis, 1987; 9: 98-107.
16. BHUYAN UN, DASH SC, SRIVASTAVA RN, SHARMA RK, MALHOTRA KK: Immunopathology, extent and course of glomerulonephritis with crescent formation. Clin Nephrol, 1982; 18: 280-5.
17. DROZ D : La biopsie rénale dans les glomérulonéphrites extracapillaires. In: Droz D, Lantz B, eds. La biopsie rénale. Paris : Les Éditions INSERM. 1996 : 181-97.
18. BOLTON WK: Goodpasture's syndrome. Kidney Int, 1996; 50: 1753-66.
19. JAYNE DR, MARSHALL PD, JONES SJ, LOCKWOOD CM: Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int, 1990; 37: 965-70.
20. NOEL LH, GEFFRIAUD C, CHAUVEAU D, HOUHOU S, LANDAIS P, KIRHAOUI F, et al.: Antineutrophil cytoplasm antibodies: diversity and clinical applications. Adv Nephrol Necker Hosp, 1993; 22: 237-67.
21. HAGEN EC, DAHA MR, HERMANS J, ANDRASSY K, CSERNOK E, GASKIN G, et al.: Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis: EC/BCR. Project for ANCA Assay Standardization. Kidney Int, 1998; 53: 743-53.
22. NACHMAN PH, HOGAN SL, JENNETTE JC, FALK RJ: Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol, 1996; 7: 33-9.
23. FRANSSEN CF, STEGEMAN CA, OOST-KORT WW, KALLENBERG CG, LIMBURG PC, TIEBOSCH A, et al.: Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis. J Am Soc Nephrol, 1998; 9: 1915-23.
24. RONDEAU E, LEVY M, DOSQUET P, RUEDIN P, MOUGENOT B, KANFER A, et al.: Plasma exchange and immunosuppression for rapidly progressive glomerulonephritis: prognosis and complications. Nephrol Dial Transplant, 1989; 4: 196-200.
25. FALK RJ, HOGAN SL, CAREY TS, JENNETTE JC, and The Glomerular Disease Collaborative Network: Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. Ann Intern Med, 1990; 113: 656-63.
26. MORRIN PA, HINGLAIS N, NABARRA B, KREIS H: Rapidly progressive glomerulonephritis. A clinical and pathologic study. Am J Med, 1978; 65: 446-60.
27. HEAP JG, JORGENSEN F, NIELSEN LP: Treatment and prognosis of extracapillary glomerulonephritis. Nephron, 1983; 35: 217-24.
28. BOLTON WK, STURGILL BC: Methylprednisolone therapy for acute crescentic rapidly progressive glomerulonephritis: Am J Nephrol, 1989; 9: 368-75.
29. GUILLEVIN L, LHOTE F: Treatment of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum, 1998; 41: 2100-5.
30. ADU D, PALL A, LUQMANI RA, RICHARDS NT, HOWIE AJ, EMERY P, et al.: Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. QJM. 1997; 90: 401-9.
31. GUILLEVIN L, CORDIER JF, LHOTE F, COHEN P, JARROUSSE B, ROYER I, et al.: A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum, 1997; 40: 2187-98.
32. RONDEAU E, KOURILSKY O, PERALDI MN, ALBERTI C, KANFER A, SRAER JD: Methylprednisolone and cyclophosphamide pulse therapy in crescentic glomerulonephritis: safety and effectiveness. Ren Fail, 1993; 15: 495-501.
33. KUNIS CL, KISS B, WILLIAMS G, D'AGATI V, APPEL GB: Intravenous "pulse" cyclophosphamide therapy of crescentic glomerulonephritis. Clin Nephrol, 1992; 37: 1-7.
34. FORT JG, ABRUZZO JL: Reversal of progressive necrotizing vasculitis with intravenous pulse cyclophosphamide and methylprednisolone. Arthritis Rheum, 1988; 31: 1194-8.
35. SAVAGE COS, HARPER L, ADU D: Primary systemic vasculitis: Lancet, 1997; 349: 553-7.
36. GUILLEVIN L, CEVALLOS R, DURAND GASSELIN B, LHOTE F, JARROUSSE B, CALLARD P: Treatment of glomerulonephritis in microscopic polyangiitis and Churg-Strauss syndrome: Indications of plasma exchanges, Meta-analysis of 2 randomized studies on 140 patients, 32 with glomerulonephritis. Ann Med Interne, 1997; 148: 198-204.
37. GLOCKNER WM, SIEBERTH HG, WICHMANN HE, BACKES E, BAMBAUER R, BOESKEN WH, BOHLE A, DAUL A, GRABEN N, KELLER F, KLEHR HU, KÖHLER H, METZ U, SCHULTZ W, THOENES W, VLAHO M: Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study. Clin Nephrol, 1988; 29: 1-8.
38. GORDON M, LUQMANI RA, ADU D, GREAVES I, RICHARDS N, MICHAEL J, EMERY P, HOWIE AJ, BACON PA: Relapses in patients with a systemic vasculitis: Q J Med, 1993; 86: 779-89.
39. GASKIN G, SAVAGE COS, RYAN JJ, JONES S, REES AJ, LOCKWOOD CM, PUSEY CD: Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with sytemic vasculitis. Nephrol Dial Transplant, 1991; 6: 689-94.